{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:28:00Z","timestamp":1786991280986,"version":"build-2736575974"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T00:00:00Z","timestamp":1752796800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001779","name":"Monash University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001779","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001782","name":"University of Melbourne","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001782","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100024218","name":"Florey Institute of Neuroscience and Mental Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100024218","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.jad.2025.119866","type":"journal-article","created":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T15:23:23Z","timestamp":1752765803000},"page":"119866","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Development of an Australian Clinical Practice Guideline on methylenedioxymethamphetamine (MDMA)-assisted Psychotherapy for Post-traumatic Stress Disorder"],"prefix":"10.1016","volume":"391","author":[{"given":"Alene Sze Jing","family":"Yong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sue E.","family":"Brennan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzie","family":"Bratuskins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aim\u00e9e","family":"Freeburn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gillinder","family":"Bedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rimona","family":"Burke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terry","family":"Haines","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Hollick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberley Ann","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Lawrence","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong Yi","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander C.","family":"McFarlane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Parker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Procter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liam","family":"Spicer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew A.","family":"Somogyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Stafrace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stacey","family":"Watts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clare","family":"Walton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kay","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Simon","family":"Bell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2025.119866_bb0005","article-title":"GRADE evidence to decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 1: introduction","volume":"353","author":"Alonso-Coello","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.jad.2025.119866_bb0010","doi-asserted-by":"crossref","unstructured":"Alonso-Coello, P., Oxman, A. D., Moberg, J., Brignardello-Petersen, R., Akl, E. A., Davoli, M., Treweek, S., Mustafa, R. A., Vandvik, P. O., & Meerpohl, J. (2017). GRADE evidence to decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 2: Clinical practice guidelines. Gac. Sanit., 32(2), 167. e161-167. (e110).","DOI":"10.1136\/bmj.i2089"},{"issue":"7","key":"10.1016\/j.jad.2025.119866_bb0015","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.jclinepi.2012.03.013","article-title":"GRADE guidelines: 14. Going from evidence to recommendations: the significance and presentation of recommendations","volume":"66","author":"Andrews","year":"2013","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.jad.2025.119866_bb0020","series-title":"Australian Code for the Responsible Conduct of Research","author":"Australia Universities","year":"2018"},{"key":"10.1016\/j.jad.2025.119866_bb0025","author":"Australian Indigenous Doctors' Association"},{"issue":"6","key":"10.1016\/j.jad.2025.119866_bb0030","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1097\/NMD.0000000000000828","article-title":"A survey of American psychiatrists\u2019 attitudes toward classic hallucinogens","volume":"206","author":"Barnett","year":"2018","journal-title":"J. Nerv. Ment. Dis."},{"issue":"3","key":"10.1016\/j.jad.2025.119866_bb0035","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1080\/02791072.2021.1957183","article-title":"Psychedelic knowledge and opinions in psychiatrists at two professional conferences: an exploratory survey","volume":"54","author":"Barnett","year":"2022","journal-title":"J. Psychoactive Drugs"},{"issue":"2","key":"10.1016\/j.jad.2025.119866_bb0040","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1177\/10398562231156684","article-title":"The prescription of psychedelic therapies in Australia and New Zealand: a brief survey of psychiatrists","volume":"31","author":"Berger","year":"2023","journal-title":"Australas. Psychiatry"},{"issue":"4","key":"10.1016\/j.jad.2025.119866_bb0045","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1002\/jts.22421","article-title":"The international society for traumatic stress studies new guidelines for the prevention and treatment of posttraumatic stress disorder: methodology and development process","volume":"32","author":"Bisson","year":"2019","journal-title":"J. Trauma. Stress."},{"key":"10.1016\/j.jad.2025.119866_bb0050","unstructured":"Braun, V., & Clarke, V. 2021. Thematic analysis: a practical guide. SAGE (Publications)."},{"key":"10.1016\/j.jad.2025.119866_bb0055","doi-asserted-by":"crossref","DOI":"10.1038\/s41386-024-01865-8","article-title":"Side-effects of mdma-assisted psychotherapy: a systematic review and meta-analysis","author":"Colcott","year":"2024","journal-title":"Neuropsychopharmacology"},{"issue":"8","key":"10.1016\/j.jad.2025.119866_bb0060","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003262","article-title":"Psychological and pharmacological interventions for posttraumatic stress disorder and comorbid mental health problems following complex traumatic events: systematic review and component network meta-analysis","volume":"17","author":"Coventry","year":"2020","journal-title":"PLoS Med."},{"issue":"3","key":"10.1016\/j.jad.2025.119866_bb0065","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1136\/bmjebm-2022-111962","article-title":"Good or best practice statements: proposal for the operationalisation and implementation of GRADE guidance","volume":"28","author":"Dewidar","year":"2023","journal-title":"BMJ Evid. Based Med."},{"key":"10.1016\/j.jad.2025.119866_bb0070","author":"Food and Drug Administration"},{"key":"10.1016\/j.jad.2025.119866_bb0075","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.jclinepi.2021.11.025","article-title":"Transparency: a central principle underpinning trustworthy guidelines","volume":"142","author":"Ford","year":"2022","journal-title":"J. Clin. Epidemiol."},{"issue":"1","key":"10.1016\/j.jad.2025.119866_bb0080","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s13012-016-0399-1","article-title":"Integrated knowledge translation (IKT) in health care: a scoping review","volume":"11","author":"Gagliardi","year":"2016","journal-title":"Implement. Sci."},{"issue":"2","key":"10.1016\/j.jad.2025.119866_bb0085","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1136\/jech-2016-207743","article-title":"Research agenda for integrated knowledge translation (IKT) in healthcare: what we know and do not yet know","volume":"71","author":"Gagliardi","year":"2017","journal-title":"J. Epidemiol. Community Health"},{"issue":"1","key":"10.1016\/j.jad.2025.119866_bb0090","first-page":"46","article-title":"Getting evidence into policy and practice: perspective of a health research funder","volume":"18","author":"Graham","year":"2009","journal-title":"J. Can. Acad. Child Adolesc. Psychiatry"},{"issue":"4","key":"10.1016\/j.jad.2025.119866_bb0095","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jclinepi.2010.09.012","article-title":"GRADE guidelines: 2. Framing the question and deciding on important outcomes","volume":"64","author":"Guyatt","year":"2011","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.jad.2025.119866_bb0100","author":"Heath"},{"key":"10.1016\/j.jad.2025.119866_bb0105","series-title":"Cochrane handbook for systematic reviews of interventions","first-page":"205","article-title":"Assessing risk of bias in a randomized trial","author":"Higgins","year":"2019"},{"key":"10.1016\/j.jad.2025.119866_bb0110","author":"International Society for Traumatic Stress Studies"},{"issue":"1","key":"10.1016\/j.jad.2025.119866_bb0115","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/s13012-017-0696-3","article-title":"Community-based participatory research and integrated knowledge translation: advancing the co-creation of knowledge","volume":"12","author":"Jull","year":"2017","journal-title":"Implement. Sci."},{"issue":"11","key":"10.1016\/j.jad.2025.119866_bb0120","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1017\/S0033291719000436","article-title":"Psychological interventions for ICD-11 complex PTSD symptoms: systematic review and meta-analysis","volume":"49","author":"Karatzias","year":"2019","journal-title":"Psychol. Med."},{"issue":"3","key":"10.1016\/j.jad.2025.119866_bb0125","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1177\/00048674221083868","article-title":"A systematic literature review and meta-analysis of the effect of psilocybin and methylenedioxymethamphetamine on mental, behavioural or developmental disorders","volume":"57","author":"Kisely","year":"2023","journal-title":"Austr. N.Z. J. Psychiatry"},{"issue":"2","key":"10.1016\/j.jad.2025.119866_bb0130","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.healthpol.2012.11.004","article-title":"A critical second look at integrated knowledge translation","volume":"109","author":"Kothari","year":"2013","journal-title":"Health Policy"},{"issue":"6","key":"10.1016\/j.jad.2025.119866_bb0135","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1002\/cpp.2880","article-title":"Psychologists\u2019 and psychotherapists\u2019 knowledge, attitudes, and clinical practices regarding the therapeutic use of psychedelics","volume":"30","author":"Kucsera","year":"2023","journal-title":"Clin. Psychol. Psychother."},{"key":"10.1016\/j.jad.2025.119866_bb0140","series-title":"Attitudes and Beliefs about the Medically Supervised Use of Psychedelic Medications for the Treatment of Mental Health Conditions","author":"Kunstler","year":"2022"},{"issue":"3","key":"10.1016\/j.jad.2025.119866_bb0145","doi-asserted-by":"crossref","DOI":"10.17061\/phrp3332321","article-title":"\u201cWe don\u2019t want to run before we walk\u201d: the attitudes of Australian stakeholders towards using psychedelics for mental health conditions","volume":"33","author":"Kunstler","year":"2023","journal-title":"Public Health Res. Pract."},{"key":"10.1016\/j.jad.2025.119866_bb0150","unstructured":"Lykos Therapeutics. (2024, 9 August 2024). Lykos Therapeutics Announces Complete Response Letter for Midomafetamine Capsules for PTSD https:\/\/news.lykospbc.com\/2024-08-09-Lykos-Therapeutics-Announces-Complete-Response-Letter-for-Midomafetamine-Capsules-for-PTSD."},{"issue":"4","key":"10.1016\/j.jad.2025.119866_bb0155","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1017\/S0033291720000070","article-title":"Psychological treatments for post-traumatic stress disorder in adults: a network meta-analysis","volume":"50","author":"Mavranezouli","year":"2020","journal-title":"Psychol. Med."},{"issue":"6","key":"10.1016\/j.jad.2025.119866_bb0160","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1038\/s41591-021-01336-3","article-title":"MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study","volume":"27","author":"Mitchell","year":"2021","journal-title":"Nat. Med."},{"issue":"10","key":"10.1016\/j.jad.2025.119866_bb0165","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1038\/s41591-023-02565-4","article-title":"MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial","volume":"29","author":"Mitchell","year":"2023","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.jad.2025.119866_bb0170","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s13011-022-00468-0","article-title":"Safety considerations in the evolving legal landscape of psychedelic-assisted psychotherapy","volume":"17","author":"Mocanu","year":"2022","journal-title":"Subst. Abuse Treat. Prev. Policy"},{"key":"10.1016\/j.jad.2025.119866_bb0175","author":"Mustafa"},{"issue":"10","key":"10.1016\/j.jad.2025.119866_bb0180","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1177\/00048674241261779","article-title":"Attitudes toward psychedelics and psychedelic-assisted therapy among potential mental health service users and the general population in Australia","volume":"58","author":"Nadeem","year":"2024","journal-title":"Austr. N.Z. J. Psychiatry"},{"key":"10.1016\/j.jad.2025.119866_bb0185","unstructured":"Nadeem Z. Parker S. McGovern H. Sebben B. Oestreich L. n.d. Attitudes toward Psychedelics and Psychedelic-Assisted Therapy among Potential Mental Healthcare Providers. Unpublished manuscript, The University of Queensland."},{"key":"10.1016\/j.jad.2025.119866_bb0190","author":"National Health and Medical Research Council"},{"key":"10.1016\/j.jad.2025.119866_bb0195","series-title":"22\/11\/2018","author":"National Health and Medical Research Council","year":"2018"},{"key":"10.1016\/j.jad.2025.119866_bb0200","series-title":"Disclosure of interests and management of conflicts of interest: A guide supporting the Australian Code for the Responsible Conduct of Research","author":"National Health and Medical Research Council","year":"2019"},{"key":"10.1016\/j.jad.2025.119866_bb0210","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jclinepi.2022.03.017","article-title":"Using explicit thresholds were valuable for judging benefits and harms in partially contextualized GRADE guidelines","volume":"147","author":"Neumann","year":"2022","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.jad.2025.119866_bb0215","unstructured":"Neumann, I., Brennan, S., Meerpohl, J., Davoli, M., Alonso Coello, P., Akl, E., Dahm, P., Skoetz, N., Xia, J., Brozek, J., & Sch\u00fcnemann, H. J. (2025). Overview of the GRADE approach. In Neumann, I. & Sch\u00fcnemann, H. (Eds.), The GRADE Book (Version 1.0 Ed.). The GRADE Working Group. https:\/\/book.gradepro.org\/guideline\/overview-of-the-grade-approach."},{"key":"10.1016\/j.jad.2025.119866_bb0220","article-title":"Using a MDMA- and LSD-group therapy model in clinical practice in Switzerland and highlighting the treatment of trauma-related disorders","volume":"13","author":"Oehen","year":"2022","journal-title":"Front. Psych."},{"key":"10.1016\/j.jad.2025.119866_bb0225","article-title":"The readiness of psychiatrists to implement psychedelic-assisted psychotherapy","volume":"12","author":"Page","year":"2021","journal-title":"Front. Psych."},{"key":"10.1016\/j.jad.2025.119866_bb0230","series-title":"Australian Guidelines for the Treatment of Acute Stress Disorder, Posttraumatic Stress Disorder, and Complex PTSD in.","author":"Phoenix Australia","year":"2020"},{"issue":"4","key":"10.1016\/j.jad.2025.119866_bb0235","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.jclinepi.2013.11.007","article-title":"Systematic review finds overlapping reviews were not mentioned in every other overview","volume":"67","author":"Pieper","year":"2014","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.jad.2025.119866_bb0240","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jclinepi.2020.07.022","article-title":"Supporting effective participation in health guideline development groups: the guideline participant tool","volume":"130","author":"Piggott","year":"2021","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.jad.2025.119866_bb0245","author":"Psychedelic Alpha"},{"issue":"5","key":"10.1016\/j.jad.2025.119866_bb0250","doi-asserted-by":"crossref","first-page":"354","DOI":"10.7326\/M18-3279","article-title":"Disclosure of interests and management of conflicts of interest in clinical guidelines and guidance statements: methods from the clinical guidelines committee of the American College of Physicians","volume":"171","author":"Qaseem","year":"2019","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.jad.2025.119866_bb0255","author":"Royal Australian and New Zealand College of Psychiatrists"},{"key":"10.1016\/j.jad.2025.119866_bb0260","author":"Royal Australian College of General Practitioners"},{"key":"10.1016\/j.jad.2025.119866_bb0265","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jclinepi.2019.10.014","article-title":"GRADE guidelines 26: informative statements to communicate the findings of systematic reviews of interventions","volume":"119","author":"Santesso","year":"2020","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.jad.2025.119866_bb0270","unstructured":"Sch\u00fcnemann, H., Higgins, J., Vist, G., Glasziou, P., Akl, E., Skoetz, N., & Guyatt, G. (2024). Chapter 14: Completing \u2018summary of findings\u2019 tables and grading the certainty of the evidence [last updated august 2023]. In Higgins, J., Thomas, J., Chandler, J., Cumpston, M., Li, T., Page, M., & Welch, V. (Eds.), Cochrane Handbook for Systematic Reviews of Interventions (version 6.5 ed.). Cochrane https:\/\/www.cochrane.org\/authors\/handbooks-and-manuals\/handbook\/current\/chapter-14."},{"issue":"7","key":"10.1016\/j.jad.2025.119866_bb0275","doi-asserted-by":"crossref","first-page":"548","DOI":"10.7326\/M14-1885","article-title":"Guidelines international network: principles for disclosure of interests and management of conflicts in guidelines","volume":"163","author":"Sch\u00fcnemann","year":"2015","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.jad.2025.119866_bb0280","article-title":"AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both","volume":"358","author":"Shea","year":"2017","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.jad.2025.119866_bb0285","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1001\/jamapsychiatry.2022.4101","article-title":"Psychedelic drug legislative reform and legalization in the US","volume":"80","author":"Siegel","year":"2023","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jad.2025.119866_bb0290","author":"The GRADE Working Group"},{"key":"10.1016\/j.jad.2025.119866_bb0295","unstructured":"Therapeutic Goods Administration. (2023, 3 July 2023). Update on MDMA and psilocybin access and safeguards from 1 July 2023 https:\/\/www.tga.gov.au\/news\/news\/update-mdma-and-psilocybin-access-and-safeguards-1-july-2023."},{"key":"10.1016\/j.jad.2025.119866_bb0300","author":"Therapeutic Goods Administration"},{"key":"10.1016\/j.jad.2025.119866_bb0305","author":"We Al-li"},{"issue":"4","key":"10.1016\/j.jad.2025.119866_bb0310","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1177\/00048674251315642","article-title":"Safety and efficacy of methylenedioxymethamphetamine (MDMA)-assisted psychotherapy in post-traumatic stress disorder: an overview of systematic reviews and meta-analyses","volume":"59","author":"Yong","year":"2025","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"10.1016\/j.jad.2025.119866_bb0315","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jclinepi.2021.03.026","article-title":"GRADE guidelines 32: GRADE offers guidance on choosing targets of GRADE certainty of evidence ratings","volume":"137","author":"Zeng","year":"2021","journal-title":"J. Clin. Epidemiol."}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032725013084?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032725013084?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T05:03:49Z","timestamp":1779858229000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032725013084"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":62,"alternative-id":["S0165032725013084"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2025.119866","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of an Australian Clinical Practice Guideline on methylenedioxymethamphetamine (MDMA)-assisted Psychotherapy for Post-traumatic Stress Disorder","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2025.119866","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"119866"}}